Company profile for Nutriband

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nutriband is primarily engaged in the development of a portfolio of transdermal(delivered through the skin) pharmaceutical products. Our lead product is our AVERSA technology. AVERSA™ abuse deterrent transdermal technology incorporates aversive agents to prevent the Abuse, DiVERsion, MiSuse and Accidental exposure of drugs with abuse potential specifically Opioids. Our first application for AVERSA is for our abuse deterrent...
Nutriband is primarily engaged in the development of a portfolio of transdermal(delivered through the skin) pharmaceutical products. Our lead product is our AVERSA technology. AVERSA™ abuse deterrent transdermal technology incorporates aversive agents to prevent the Abuse, DiVERsion, MiSuse and Accidental exposure of drugs with abuse potential specifically Opioids. Our first application for AVERSA is for our abuse deterrent fentanyl transdermal patch which we are developing to provide clinicians and patients with an extended release chronic pain relief.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
121 S. Orange Ave., Suite 1500, Orlando, FL 32801
Telephone
Telephone
+1 (407) 377 6696
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.contractpharma.com/breaking-news/nutriband-kindeva-complete-commercial-scale-up-for-aversa-fentanyl/

CONTRACTPHARMA
23 Jun 2025

https://www.contractpharma.com/breaking-news/nutriband-and-kindeva-to-co-develop-aversa-fentanyl-abuse-deterrent-patch/

CONTRACTPHARMA
12 Feb 2025

https://www.accesswire.com/937286/nutriband-inc-issued-full-patent-from-the-chinese-national-intellectual-property-administrant-for-its-abuse-and-misuse-deterrent-transdermal-system-application

ACCESSWIRE
31 Oct 2024

https://www.accesswire.com/932563/nutriband-inc-mosquito-repellent-patch-approved-by-ministry-of-health-of-costa-rica

ACCESSWIRE
17 Oct 2024

https://www.accesswire.com/920557/nutriband-licenses-bitrexr-brand-aversive-agent-for-its-lead-product-aversatm-fentanyl-transdermal-patch

ACCESSWIRE
20 Sep 2024

https://www.accesswire.com/918230/nutriband-inc-authorizes-1m-share-buyback-program

ACCESSWIRE
16 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty